Click for best price
Alternatesite Infusion Therapy Market Size, Share 2022
Infusion therapy?refers to the administration of medications through a needle or a catheter. Although drugs are typically administered intravenously,?infusion therapy?includes the administration of medication by way of intramuscular injections or epidural routes.
This report contains market size and forecasts of Alternate-site Infusion Therapy in Global, including the following market information:
Global Alternate-site Infusion Therapy Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global top five companies in 2021 (%)
The global Alternate-site Infusion Therapy market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Administer Drug Intravenously Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Alternate-site Infusion Therapy include Option Care Health, Coram CVS, UnitedHealth Group, HCA Healthcare, McLaren, CHI Health, Accredo Health, PharMerica and Cleveland Clinic. etc. In 2021, the global top five players have a share approximately % in terms of revenue.
We surveyed the Alternate-site Infusion Therapy companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Alternate-site Infusion Therapy Market, by Type, 2017-2022, 2023-2028 ($ millions)
Global Alternate-site Infusion Therapy Market Segment Percentages, by Type, 2021 (%)
Administer Drug Intravenously
Other Nnon-oral Routes
Global Alternate-site Infusion Therapy Market, by Application, 2017-2022, 2023-2028 ($ millions)
Global Alternate-site Infusion Therapy Market Segment Percentages, by Application, 2021 (%)
Cancer
Chronic Disease
Others
Global Alternate-site Infusion Therapy Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)
Global Alternate-site Infusion Therapy Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Alternate-site Infusion Therapy revenues in global market, 2017-2022 (estimated), ($ millions)
Key companies Alternate-site Infusion Therapy revenues share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Option Care Health
Coram CVS
UnitedHealth Group
HCA Healthcare
McLaren
CHI Health
Accredo Health
PharMerica
Cleveland Clinic
| Report Attributes |
Report Details |
| Report Title |
Alternate-site Infusion Therapy Market - Global Outlook and Forecast 2022-2028 |
| Historical Year |
2018 to 2022 (Data from 2010 can be provided as per availability) |
| Base Year |
2021 |
| Forecast Year |
2029 |
| Number of Pages |
69 Pages |
| Customization Available |
Yes, the report can be customized as per your need. |
TABLE OF CONTENTS
1 Introduction to Research & Analysis Reports
1.1 Alternate-site Infusion Therapy Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Alternate-site Infusion Therapy Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Alternate-site Infusion Therapy Overall Market Size
2.1 Global Alternate-site Infusion Therapy Market Size: 2021 VS 2028
2.2 Global Alternate-site Infusion Therapy Market Size, Prospects & Forecasts: 2017-2028
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Alternate-site Infusion Therapy Players in Global Market
3.2 Top Global Alternate-site Infusion Therapy Companies Ranked by Revenue
3.3 Global Alternate-site Infusion Therapy Revenue by Companies
3.4 Top 3 and Top 5 Alternate-site Infusion Therapy Companies in Global Market, by Revenue in 2021
3.5 Global Companies Alternate-site Infusion Therapy Product Type
3.6 Tier 1, Tier 2 and Tier 3 Alternate-site Infusion Therapy Players in Global Market
3.6.1 List of Global Tier 1 Alternate-site Infusion Therapy Companies
3.6.2 List of Global Tier 2 and Tier 3 Alternate-site Infusion Therapy Companies
4 Market Sights by Product
4.1 Overview
4.1.1 by Type - Global Alternate-site Infusion Therapy Market Size Markets, 2021 & 2028
4.1.2 Administer Drug Intravenously
4.1.3 Other Nnon-oral Routes
4.2 By Type - Global Alternate-site Infusion Therapy Revenue & Forecasts
4.2.1 By Type - Global Alternate-site Infusion Therapy Revenue, 2017-2022
4.2.2 By Type - Global Alternate-site Infusion Therapy Revenue, 2023-2028
4.2.3 By Type - Global Alternate-site Infusion Therapy Revenue Market Share, 2017-2028
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Alternate-site Infusion Therapy Market Size, 2021 & 2028
5.1.2 Cancer
5.1.3 Chronic Disease
5.1.4 Others
5.2 By Application - Global Alternate-site Infusion Therapy Revenue & Forecasts
5.2.1 By Application - Global Alternate-site Infusion Therapy Revenue, 2017-2022
5.2.2 By Application - Global Alternate-site Infusion Therapy Revenue, 2023-2028
5.2.3 By Application - Global Alternate-site Infusion Therapy Revenue Market Share, 2017-2028
6 Sights by Region
6.1 By Region - Global Alternate-site Infusion Therapy Market Size, 2021 & 2028
6.2 By Region - Global Alternate-site Infusion Therapy Revenue & Forecasts
6.2.1 By Region - Global Alternate-site Infusion Therapy Revenue, 2017-2022
6.2.2 By Region - Global Alternate-site Infusion Therapy Revenue, 2023-2028
6.2.3 By Region - Global Alternate-site Infusion Therapy Revenue Market Share, 2017-2028
6.3 North America
6.3.1 By Country - North America Alternate-site Infusion Therapy Revenue, 2017-2028
6.3.2 US Alternate-site Infusion Therapy Market Size, 2017-2028
6.3.3 Canada Alternate-site Infusion Therapy Market Size, 2017-2028
6.3.4 Mexico Alternate-site Infusion Therapy Market Size, 2017-2028
6.4 Europe
6.4.1 By Country - Europe Alternate-site Infusion Therapy Revenue, 2017-2028
6.4.2 Germany Alternate-site Infusion Therapy Market Size, 2017-2028
6.4.3 France Alternate-site Infusion Therapy Market Size, 2017-2028
6.4.4 U.K. Alternate-site Infusion Therapy Market Size, 2017-2028
6.4.5 Italy Alternate-site Infusion Therapy Market Size, 2017-2028
6.4.6 Russia Alternate-site Infusion Therapy Market Size, 2017-2028
6.4.7 Nordic Countries Alternate-site Infusion Therapy Market Size, 2017-2028
6.4.8 Benelux Alternate-site Infusion Therapy Market Size, 2017-2028
6.5 Asia
6.5.1 By Region - Asia Alternate-site Infusion Therapy Revenue, 2017-2028
6.5.2 China Alternate-site Infusion Therapy Market Size, 2017-2028
6.5.3 Japan Alternate-site Infusion Therapy Market Size, 2017-2028
6.5.4 South Korea Alternate-site Infusion Therapy Market Size, 2017-2028
6.5.5 Southeast Asia Alternate-site Infusion Therapy Market Size, 2017-2028
6.5.6 India Alternate-site Infusion Therapy Market Size, 2017-2028
6.6 South America
6.6.1 By Country - South America Alternate-site Infusion Therapy Revenue, 2017-2028
6.6.2 Brazil Alternate-site Infusion Therapy Market Size, 2017-2028
6.6.3 Argentina Alternate-site Infusion Therapy Market Size, 2017-2028
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Alternate-site Infusion Therapy Revenue, 2017-2028
6.7.2 Turkey Alternate-site Infusion Therapy Market Size, 2017-2028
6.7.3 Israel Alternate-site Infusion Therapy Market Size, 2017-2028
6.7.4 Saudi Arabia Alternate-site Infusion Therapy Market Size, 2017-2028
6.7.5 UAE Alternate-site Infusion Therapy Market Size, 2017-2028
7 Players Profiles
7.1 Option Care Health
7.1.1 Option Care Health Corporate Summary
7.1.2 Option Care Health Business Overview
7.1.3 Option Care Health Alternate-site Infusion Therapy Major Product Offerings
7.1.4 Option Care Health Alternate-site Infusion Therapy Revenue in Global Market (2017-2022)
7.1.5 Option Care Health Key News
7.2 Coram CVS
7.2.1 Coram CVS Corporate Summary
7.2.2 Coram CVS Business Overview
7.2.3 Coram CVS Alternate-site Infusion Therapy Major Product Offerings
7.2.4 Coram CVS Alternate-site Infusion Therapy Revenue in Global Market (2017-2022)
7.2.5 Coram CVS Key News
7.3 UnitedHealth Group
7.3.1 UnitedHealth Group Corporate Summary
7.3.2 UnitedHealth Group Business Overview
7.3.3 UnitedHealth Group Alternate-site Infusion Therapy Major Product Offerings
7.3.4 UnitedHealth Group Alternate-site Infusion Therapy Revenue in Global Market (2017-2022)
7.3.5 UnitedHealth Group Key News
7.4 HCA Healthcare
7.4.1 HCA Healthcare Corporate Summary
7.4.2 HCA Healthcare Business Overview
7.4.3 HCA Healthcare Alternate-site Infusion Therapy Major Product Offerings
7.4.4 HCA Healthcare Alternate-site Infusion Therapy Revenue in Global Market (2017-2022)
7.4.5 HCA Healthcare Key News
7.5 McLaren
7.5.1 McLaren Corporate Summary
7.5.2 McLaren Business Overview
7.5.3 McLaren Alternate-site Infusion Therapy Major Product Offerings
7.5.4 McLaren Alternate-site Infusion Therapy Revenue in Global Market (2017-2022)
7.5.5 McLaren Key News
7.6 CHI Health
7.6.1 CHI Health Corporate Summary
7.6.2 CHI Health Business Overview
7.6.3 CHI Health Alternate-site Infusion Therapy Major Product Offerings
7.6.4 CHI Health Alternate-site Infusion Therapy Revenue in Global Market (2017-2022)
7.6.5 CHI Health Key News
7.7 Accredo Health
7.7.1 Accredo Health Corporate Summary
7.7.2 Accredo Health Business Overview
7.7.3 Accredo Health Alternate-site Infusion Therapy Major Product Offerings
7.7.4 Accredo Health Alternate-site Infusion Therapy Revenue in Global Market (2017-2022)
7.7.5 Accredo Health Key News
7.8 PharMerica
7.8.1 PharMerica Corporate Summary
7.8.2 PharMerica Business Overview
7.8.3 PharMerica Alternate-site Infusion Therapy Major Product Offerings
7.8.4 PharMerica Alternate-site Infusion Therapy Revenue in Global Market (2017-2022)
7.8.5 PharMerica Key News
7.9 Cleveland Clinic
7.9.1 Cleveland Clinic Corporate Summary
7.9.2 Cleveland Clinic Business Overview
7.9.3 Cleveland Clinic Alternate-site Infusion Therapy Major Product Offerings
7.9.4 Cleveland Clinic Alternate-site Infusion Therapy Revenue in Global Market (2017-2022)
7.9.5 Cleveland Clinic Key News
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. Alternate-site Infusion Therapy Market Opportunities & Trends in Global Market
Table 2. Alternate-site Infusion Therapy Market Drivers in Global Market
Table 3. Alternate-site Infusion Therapy Market Restraints in Global Market
Table 4. Key Players of Alternate-site Infusion Therapy in Global Market
Table 5. Top Alternate-site Infusion Therapy Players in Global Market, Ranking by Revenue (2021)
Table 6. Global Alternate-site Infusion Therapy Revenue by Companies, (US$, Mn), 2017-2022
Table 7. Global Alternate-site Infusion Therapy Revenue Share by Companies, 2017-2022
Table 8. Global Companies Alternate-site Infusion Therapy Product Type
Table 9. List of Global Tier 1 Alternate-site Infusion Therapy Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Alternate-site Infusion Therapy Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type ? Global Alternate-site Infusion Therapy Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Alternate-site Infusion Therapy Revenue in Global (US$, Mn), 2017-2022
Table 13. By Type - Alternate-site Infusion Therapy Revenue in Global (US$, Mn), 2023-2028
Table 14. By Application ? Global Alternate-site Infusion Therapy Revenue, (US$, Mn), 2021 & 2028
Table 15. By Application - Alternate-site Infusion Therapy Revenue in Global (US$, Mn), 2017-2022
Table 16. By Application - Alternate-site Infusion Therapy Revenue in Global (US$, Mn), 2023-2028
Table 17. By Region ? Global Alternate-site Infusion Therapy Revenue, (US$, Mn), 2021 & 2028
Table 18. By Region - Global Alternate-site Infusion Therapy Revenue (US$, Mn), 2017-2022
Table 19. By Region - Global Alternate-site Infusion Therapy Revenue (US$, Mn), 2023-2028
Table 20. By Country - North America Alternate-site Infusion Therapy Revenue, (US$, Mn), 2017-2022
Table 21. By Country - North America Alternate-site Infusion Therapy Revenue, (US$, Mn), 2023-2028
Table 22. By Country - Europe Alternate-site Infusion Therapy Revenue, (US$, Mn), 2017-2022
Table 23. By Country - Europe Alternate-site Infusion Therapy Revenue, (US$, Mn), 2023-2028
Table 24. By Region - Asia Alternate-site Infusion Therapy Revenue, (US$, Mn), 2017-2022
Table 25. By Region - Asia Alternate-site Infusion Therapy Revenue, (US$, Mn), 2023-2028
Table 26. By Country - South America Alternate-site Infusion Therapy Revenue, (US$, Mn), 2017-2022
Table 27. By Country - South America Alternate-site Infusion Therapy Revenue, (US$, Mn), 2023-2028
Table 28. By Country - Middle East & Africa Alternate-site Infusion Therapy Revenue, (US$, Mn), 2017-2022
Table 29. By Country - Middle East & Africa Alternate-site Infusion Therapy Revenue, (US$, Mn), 2023-2028
Table 30. Option Care Health Corporate Summary
Table 31. Option Care Health Alternate-site Infusion Therapy Product Offerings
Table 32. Option Care Health Alternate-site Infusion Therapy Revenue (US$, Mn), (2017-2022)
Table 33. Coram CVS Corporate Summary
Table 34. Coram CVS Alternate-site Infusion Therapy Product Offerings
Table 35. Coram CVS Alternate-site Infusion Therapy Revenue (US$, Mn), (2017-2022)
Table 36. UnitedHealth Group Corporate Summary
Table 37. UnitedHealth Group Alternate-site Infusion Therapy Product Offerings
Table 38. UnitedHealth Group Alternate-site Infusion Therapy Revenue (US$, Mn), (2017-2022)
Table 39. HCA Healthcare Corporate Summary
Table 40. HCA Healthcare Alternate-site Infusion Therapy Product Offerings
Table 41. HCA Healthcare Alternate-site Infusion Therapy Revenue (US$, Mn), (2017-2022)
Table 42. McLaren Corporate Summary
Table 43. McLaren Alternate-site Infusion Therapy Product Offerings
Table 44. McLaren Alternate-site Infusion Therapy Revenue (US$, Mn), (2017-2022)
Table 45. CHI Health Corporate Summary
Table 46. CHI Health Alternate-site Infusion Therapy Product Offerings
Table 47. CHI Health Alternate-site Infusion Therapy Revenue (US$, Mn), (2017-2022)
Table 48. Accredo Health Corporate Summary
Table 49. Accredo Health Alternate-site Infusion Therapy Product Offerings
Table 50. Accredo Health Alternate-site Infusion Therapy Revenue (US$, Mn), (2017-2022)
Table 51. PharMerica Corporate Summary
Table 52. PharMerica Alternate-site Infusion Therapy Product Offerings
Table 53. PharMerica Alternate-site Infusion Therapy Revenue (US$, Mn), (2017-2022)
Table 54. Cleveland Clinic Corporate Summary
Table 55. Cleveland Clinic Alternate-site Infusion Therapy Product Offerings
Table 56. Cleveland Clinic Alternate-site Infusion Therapy Revenue (US$, Mn), (2017-2022)
List of Figures
Figure 1. Alternate-site Infusion Therapy Segment by Type in 2021
Figure 2. Alternate-site Infusion Therapy Segment by Application in 2021
Figure 3. Global Alternate-site Infusion Therapy Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Alternate-site Infusion Therapy Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Alternate-site Infusion Therapy Revenue, 2017-2028 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Alternate-site Infusion Therapy Revenue in 2021
Figure 8. By Type - Global Alternate-site Infusion Therapy Revenue Market Share, 2017-2028
Figure 9. By Application - Global Alternate-site Infusion Therapy Revenue Market Share, 2017-2028
Figure 10. By Region - Global Alternate-site Infusion Therapy Revenue Market Share, 2017-2028
Figure 11. By Country - North America Alternate-site Infusion Therapy Revenue Market Share, 2017-2028
Figure 12. US Alternate-site Infusion Therapy Revenue, (US$, Mn), 2017-2028
Figure 13. Canada Alternate-site Infusion Therapy Revenue, (US$, Mn), 2017-2028
Figure 14. Mexico Alternate-site Infusion Therapy Revenue, (US$, Mn), 2017-2028
Figure 15. By Country - Europe Alternate-site Infusion Therapy Revenue Market Share, 2017-2028
Figure 16. Germany Alternate-site Infusion Therapy Revenue, (US$, Mn), 2017-2028
Figure 17. France Alternate-site Infusion Therapy Revenue, (US$, Mn), 2017-2028
Figure 18. U.K. Alternate-site Infusion Therapy Revenue, (US$, Mn), 2017-2028
Figure 19. Italy Alternate-site Infusion Therapy Revenue, (US$, Mn), 2017-2028
Figure 20. Russia Alternate-site Infusion Therapy Revenue, (US$, Mn), 2017-2028
Figure 21. Nordic Countries Alternate-site Infusion Therapy Revenue, (US$, Mn), 2017-2028
Figure 22. Benelux Alternate-site Infusion Therapy Revenue, (US$, Mn), 2017-2028
Figure 23. By Region - Asia Alternate-site Infusion Therapy Revenue Market Share, 2017-2028
Figure 24. China Alternate-site Infusion Therapy Revenue, (US$, Mn), 2017-2028
Figure 25. Japan Alternate-site Infusion Therapy Revenue, (US$, Mn), 2017-2028
Figure 26. South Korea Alternate-site Infusion Therapy Revenue, (US$, Mn), 2017-2028
Figure 27. Southeast Asia Alternate-site Infusion Therapy Revenue, (US$, Mn), 2017-2028
Figure 28. India Alternate-site Infusion Therapy Revenue, (US$, Mn), 2017-2028
Figure 29. By Country - South America Alternate-site Infusion Therapy Revenue Market Share, 2017-2028
Figure 30. Brazil Alternate-site Infusion Therapy Revenue, (US$, Mn), 2017-2028
Figure 31. Argentina Alternate-site Infusion Therapy Revenue, (US$, Mn), 2017-2028
Figure 32. By Country - Middle East & Africa Alternate-site Infusion Therapy Revenue Market Share, 2017-2028
Figure 33. Turkey Alternate-site Infusion Therapy Revenue, (US$, Mn), 2017-2028
Figure 34. Israel Alternate-site Infusion Therapy Revenue, (US$, Mn), 2017-2028
Figure 35. Saudi Arabia Alternate-site Infusion Therapy Revenue, (US$, Mn), 2017-2028
Figure 36. UAE Alternate-site Infusion Therapy Revenue, (US$, Mn), 2017-2028
Figure 37. Option Care Health Alternate-site Infusion Therapy Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 38. Coram CVS Alternate-site Infusion Therapy Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 39. UnitedHealth Group Alternate-site Infusion Therapy Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 40. HCA Healthcare Alternate-site Infusion Therapy Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 41. McLaren Alternate-site Infusion Therapy Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 42. CHI Health Alternate-site Infusion Therapy Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 43. Accredo Health Alternate-site Infusion Therapy Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 44. PharMerica Alternate-site Infusion Therapy Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 45. Cleveland Clinic Alternate-site Infusion Therapy Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
